$ULG.SI — investor discussion on X

$ULG.SI UltraGreen AI DBS: Generic competition clouds the growth outlook ■ Generic entry puts UltraGreen’s moat to the test with commercial traction as the key determinant ■ Surgeon stickiness should support surgical volumes, though we see increasing risk to ASPs ■ We expect the